References
- Albarano L, Esposito R, Ruocco N, Costantini M. 2020. Genome mining as new challenge in natural products discovery. Mar Drugs. 18(4):199–117.
- Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT, Taskforce INPS. 2021. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 20(3):200–216.
- Bae M, Moon K, Kim J, Park HJ, Lee SK, Shin J, Oh DC. 2016. Mohangic acids A-E, p-aminoacetophenonic acids from a marine-mudflat-derived Streptomyces sp. J Nat Prod. 79(2):332–339.
- Belal A. 2015. Synthesis, molecular docking and antitumor activity of novel pyrrolizines with potential as EGFR-TK inhibitors. Bioorg Chem. 59:124–129.
- Jacqueline A, Paul R, William F. 1998. Guaymasol and epiguaymasol: Aromatic triols from a deep-sea Bacillus isolate. Nat Prod Lett. 11(4):279–284.
- Khalifa SAM, Elias N, Farag MA, Chen L, Saeed A, Hegazy M-EF, Moustafa MS, Abd El-Wahed A, Al-Mousawi SM, Musharraf SG, et al. 2019. Marine natural products: a source of novel anticancer drugs. Mar Drugs. 17(9):491–431.
- Li G, Lou HX. 2018. Strategies to diversify natural products for drug discovery. Med Res Rev. 38(4):1255–1294.
- Shinde P, Banerjee P, Mandhare A. 2019. Marine natural products as source of new drugs: a patent review (2015-2018). Expert Opin Ther Pat. 29(4):283–309.
- Yeon ET, Lee JW, Lee C, Jin Q, Jang H, Lee D, Ahn JS, Hong JT, Kim Y, Lee MK, et al. 2015. neo-Clerodane diterpenoids from Scutellaria barbata and their inhibitory effects on LPS-induced nitric oxide production. J Nat Prod. 78(9):2292–2296.
- Zhou B, Qin LL, Ding WJ, Ma ZJ. 2018. Cytotoxic indolocarbazoles alkaloids from the Streptomyces sp. A65. Tetrahedron. 74(7):726–730.